Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
Recruiting · NCT04779554 · Registry updated 2026-04-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC | Abdominal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Peritoneal Diseases, adenocarcinoma, appendiceal neoplasm, carcinoma, cecal disorder, cecal neoplasm, colonic disorder, colorectal neoplasm, cystic, mucinous, and serous neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, intestinal disorder, mucinous adenocarcinoma, neoplasm, peritoneal neoplasm, pseudomyxoma peritonei, rectal disorder | Recruiting | Phase 2 | 2026-04-01 | NCT04779554 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Prakash Pandalai | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Kentucky | Lexington | United States | 98 |
| University of Vermont Medical Center | Burlington | United States | 157 |